Why This Course is Important
Without this course, you risk regulatory non-compliance, potential delays in product launches, and missed opportunities to streamline market access for oncology ISH diagnostics.
Course Details
This is a self-paced eLearning course based on the Federal Register Document titled Hematology and Pathology Devices; Reclassification of In Situ Hybridization Test Systems for Use With a Corresponding Approved Oncology Therapeutic Product.
Key regulatory references include:
Course SKU
FR-26-2154-1